DMRA
Galecto, Inc.Healthcare·Biotechnology
$24.88
$1.5B market cap
Revenue
$0.0M
Free Cash Flow
$-20.0M
Rev Growth
+0.0%
FCF Margin
0.0%
P/FCF
--
EV/FCF
--
Fwd EV/EBITDA
--
Fair Value
--
Upside
--
Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.
2-Year Price History
$25.30-13.1%
Quarterly Financials & Projections
Quarterly Waterfall ($ M)
| Period | Rev | EBITDA | OpIn | NI | OCF | FCF | CapEx | Cash | Debt | Shares | ROIC | IntCov | EV/EBITDA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Act | 2026-Q1 | 0.0 | -30.7 | -30.8 | -27.8 | -20.6 | -20.6 | -0.0 | 532.9 | 1.3 | 1.3 | -35.4% | -- | -- |
| Act | 2025-Q4 | 0.0 | -201.7 | -201.7 | -200.7 | 0.6 | 0.6 | -0.0 | 257.6 | 0.1 | 1.3 | <-999% | -- | -- |
Valuation & Metrics
Market Stats
Price$24.88
Market Cap$1.5B
Enterprise Value$1000M
P/S Ratio0.0x
P/FCF--
EV/FCF--
FCF Margin (TTM)0.0%
FCF Yield-1.3%
Dividend Yield (TTM)--
Annual Dilution0.0%
CurrencyUSD
TTM Financial Snapshot
Revenue$0.0M
Net Income$-228.5M
Free Cash Flow$-20.0M
Revenue Growth (YoY)+0.0%
EBITDA Margin0.0%
Net Margin0.0%
FCF Margin0.0%
CapEx % of Revenue0.0%
SBC % of Revenue0.0%
ROIC-533.7%
WC Change % Rev0.0%
Interest Coverage--
Forward Outlook & Risk
Short Interest
Short % of Float--
Short Shares1.2M
Days to Cover5.5
Change (vs Prior)+6.7%
Need at least 2 settlement dates for chart
Employees
Headcount7
Revenue / Employee$0
Gross Profit / Employee$-9,714
Institutional Ownership
Headline & net flow
NEUTRAL
Net flow · —still filing
No float data — flow unavailable.
Ownership composition
Active
95.0%(+95.0% YoY)
54 filers
hedge / family / endowment
Retail funds
—
Fidelity, Schwab, 401(k)
Passive
1.7%(+1.7% YoY)
7 filers
Vanguard, iShares, SPDR
Market makers
0.0%(+0.0% YoY)
3 filers
Citadel, Susquehanna
Insiders
—
Form 4 — latest per insider
ActiveRetail fundsPassiveMarket makersRetail direct
Top holders
| Fund | $ value | Cost basis | Δ QoQ | Δ YoY | α life | Fund AUM |
|---|---|---|---|---|---|---|
| FMR LLC | $234M | $25.90 | +$228M | +$234M | — | $1.89T |
| Fairmount Funds Management LLC | $226M | $25.90 | +$226M | +$226M | — | $1.38B |
| Avoro Capital Advisors LLC | $98.0M | $25.90 | +$98.0M | +$98.0M | — | $10.15B |
| VR Adviser, LLC | $93.3M | $25.90 | +$93.3M | +$93.3M | — | $2.68B |
| FCPM III SERVICES B.V. | $63.2M | $25.90 | +$63.2M | +$63.2M | — | $722M |
| RA CAPITAL MANAGEMENT, L.P. | $62.1M | $25.90 | +$62.1M | +$62.1M | — | $9.44B |
| JANUS HENDERSON GROUP PLC | $61.4M | $25.90 | +$61.1M | +$61.4M | — | $209.29B |
| VIKING GLOBAL INVESTORS LP | $59.9M | $25.90 | +$59.9M | +$59.9M | — | $35.75B |
| Bellevue Group AG | $59.5M | $25.90 | +$59.5M | +$59.5M | — | $4.20B |
| Remedium Capital Partners, LLC | $53.0M | $25.90 | +$49.9M | +$53.0M | — | $281M |
| Commodore Capital LP | $50.2M | $25.90 | +$50.2M | +$50.2M | — | $1.73B |
| Cormorant Asset Management, LLC | $39.5M | $25.90 | +$39.5M | +$39.5M | — | $1.95B |
| BALYASNY ASSET MANAGEMENT LLC | $37.5M | $25.90 | +$37.5M | +$37.5M | — | $48.01B |
| a16z Capital Management, L.L.C. | $32.0M | $25.90 | +$32.0M | +$32.0M | — | $1.29B |
| PERCEPTIVE ADVISORS LLC | $31.7M | $25.90 | +$31.7M | +$31.7M | — | $5.05B |
| Point72 Asset Management, L.P. | $30.9M | $25.90 | +$28.1M | +$30.9M | — | $54.88B |
| WELLINGTON MANAGEMENT GROUP LLP | $27.4M | $25.90 | +$27.4M | +$27.4M | — | $533.98B |
| Siren, L.L.C. | $23.3M | $25.90 | +$23.3M | +$23.3M | — | $3.61B |
| BRAIDWELL LP | $23.2M | $25.90 | +$23.2M | +$23.2M | — | $2.63B |
| Vestal Point Capital, LP | $15.5M | $25.90 | +$15.5M | +$15.5M | — | $3.58B |
Cost basis is a volume-weighted estimate from accumulation periods within our 13F history; holders who built their position before our window started will show a stale basis. % above the cost basis is the unrealized gain at the current price.
Trading behavior
Smart-money alpha (lifetime, %/qtr)BULLISH
Holders
+2.23%
avg per quarter
Holders (ex-self)
—
excl. this stock
Buyers (this Q)
+2.20%
62 buyers · $1.43B in
Sellers (this Q)
+0.00%
1 sellers · $-0.00B out
alpha coverage: 99% of $ has a lifetime-alpha record
Holder behavior (holder profile)source: holder
On big dips (−10%+)
-2.9%
how holders react when this stock falls
On quiet Qs
-3.6%
−10% to +10% baseline
On rallies (+10%+)
-4.6%
how they react when this stock rises
Holders' portfolio flow this Q
-4.2%
outflows — trims may be forced
Sellers' portfolio flow this Q
+9.8%
Sellers grew AUM elsewhere — opinionated cut of this stock.
Biggest decreases this quarter
New buyers this quarter
Fairmount Funds Management LLC+$0.23BAvoro Capital Advisors LLC+$0.10BVR Adviser, LLC+$0.09BFCPM III SERVICES B.V.+$0.06BRA CAPITAL MANAGEMENT, L.P.+$0.06BVIKING GLOBAL INVESTORS LP+$0.06BBellevue Group AG+$0.06BCommodore Capital LP+$0.05BCormorant Asset Management, LLC+$0.04BBALYASNY ASSET MANAGEMENT LLC+$0.04B
Top-5 holders · 49.3%
FMR LLC--
Fairmount Funds Management LLC--
Avoro Capital Advisors LLC--
VR Adviser, LLC--
FCPM III SERVICES B.V.--
Top Holders Over Time
5-year share-count history (top 10 holders by peak, incl. exited) + price
hover the chart for per-quarter detailprice (right axis)
FMR LLC9.0MFairmount Funds Management LLC8.7MAvoro Capital Advisors LLC3.8MVR Adviser, LLC3.6MFCPM III SERVICES B.V.2.4MRA CAPITAL MANAGEMENT, L.P.2.4MJANUS HENDERSON GROUP PLC2.4MVIKING GLOBAL INVESTORS LP2.3MBellevue Group AG2.3MRemedium Capital Partners, LLC2.0M
Related Stocks
Investors who own this also own
Stocks held by the same active managers as this one, ranked by score — how much more often these appear together than random chance (1× = baseline). Excludes index ETFs and market makers; minimum 3 shared holders.
Analyst Coverage
Analyst Coverage
Price Targets
Last Quarter (1 analysts)$40.006080.0%
Last Year (1 analysts)$40.006080.0%
Current Price$24.88
Analyst Ratings
1
Buy: 1Consensus: Buy
Corporate
Order Flow (FINRA, ~3w lag)
21.9%retail
27.2%dark
week of 2026-04-13
Off-exchange volume from FINRA. Retail = non-ATS (wholesaler PFOF + broker internalization). Dark = ATS (dark-pool crossing networks, institutional). Lit-exchange = remainder.